2.1. Therapy Limits

• Printer-friendly version

1. Celecoxib is prescribed on an as needed basis in the management of acute pain or dysmenorrhea. However, treatment regimens extending beyond a two-week time period will be evaluated.
2. Celecoxib dosages used in osteoarthritis, rheumatoid arthritis, familial adenomatous polyposis, and ankylosing spondylitis may be chronically administered based on patient need.
3. Celecoxib safety and efficacy in pediatric patients 2 years of age and older with JRA for greater than a six-month treatment duration have not been established. Patient profiles containing prescriptions for JRA for greater than 6 months will be reviewed.